Instead, the identification of Her4 either by immunohistochemistry [10-13], fluorescence in-situ hybridization (FISH) [14,16], or qPCR [22] seems to be sufficient for attributing a positive impact on the course/outcome of breast cancer disease. The gene discussed is ERBB4; the disease is breast carcinoma.